Option chain shows key data for Femasys's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Femasys.

Femasys (NASDAQ:FEMY) Stock, Option Chain

Femasys

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Movers

News

Pre-Market Outlook

Trading Ideas

AUMN

BENF

BMRA

BURU

CCCC

EAST

FEMY

Intelligent Bio Solutions Inc. - Common Stock

INBS

LIFW

MULN

SMMT

SVRA

TNXP

WHLR

Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Eurozone

Commodities

Intraday Update

Markets

MGOL

SONN

Tempest Therapeutics, Inc. - Common Stock

TPST

TRVN

ZAPP

Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher

xr:d:DAFl_HSvCpE:2,j:6755793051000407071,t:23061612

ALUR

APLD

ASNS

BILI

DMTK

ESPR

GRDI

HIMX

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HROW

IBRX

Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

KAVL

LOBO

LRHC

MBIO

MOLN

NKLA

NLSP

NNVC

NYAX

OCUL

PACK

PRST

RELI

SLNH

SMCI

SRFM

SVMH

TBLT

VNDA

Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Femasys Inc

Health Care

Press Releases

Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed

Legal

Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility Treatment

Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control

Femasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

Femasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic Devices

General

Femasys Announces Peer-Reviewed Publication of Positive Safety and Efficacy Results from FemBloc® Permanent Birth Control Clinical Trials

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

Femasys Announces Partnership with CNY Fertility, National Conglomerate Network of Fertility Centers, to Offer FemaSeed in its 11 Locations

Earnings

Femasys Announces Financial Results for Year Ended December 31, 2024, and Provides Corporate Update

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Apyx Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

BioSig Technologies

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

Co-Diagnostics

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Comments

Femasys

Femasys (FEMY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga